Phase Ib/II study of imprime PGG and pembrolizumab in patients with previously treated advanced non-small cell lung cancer (NSCLC): BTCRC LUN 15-017
Furqan, Muhammad, Malhotra, Jyoti, Shergill, Ardaman, Liu Li, Mott, Sarah L., Pasquinelli, Mary M., Hulbert, Alicia, Kennedy, Kathleen, Feldman, Lawrence
- ISSN / E-ISSN
- — / —
- DOI
- 10.21037/tlcr-24-346 ↗
- Volume · Issue · Pages
- 13 · 11 · —
- Publisher
- AME Publishing Company
- Article URL
- https://tlcr.amegroups.org/article/view/93111 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
30 Nov 2024
Publisher publication date · source: Journal websites (OAI-PMH feeds of Open Journal Systems)
| Type | Date | Source |
|---|---|---|
| Publisher publication date | 30 Nov 2024 | Journal websites (OAI-PMH feeds of Open Journal Systems) |
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- Some rows of the HEC list for this period are not yet matched to a journal, so absence cannot be proved. Pending verification.
Best available information, not a definitive status: Some rows of the HEC list for this period are not yet matched to a journal, so absence cannot be proved. Pending verification.
- Journal
- Translational Lung Cancer Research
- Publication date used
- 30 Nov 2024 (Publisher publication date)
- Applicable HEC period
- 2024–25 (version 1) · 01 Oct 2024 – 31 Mar 2026
- Category
- —
- Recognition status
- Pending Verification (PERIOD_HAS_UNMATCHED_ROWS)
- Source
- —
- Verification status
- Unverified
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.